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SCIENTIFIC EDITORIAL
Evaluation of aortic stiffness to predict and prevent 
the risk of atrial fibrillation in hypertensive patients 
in their 50’s
Evaluer la rigidité aortique pour prédire et prévenir le risque de fibrillation 
auriculaire chez l’hypertendu
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CHU Rangueil, Toulouse, France.
Pulse wave velocity measurement (PWVM) is the current
“gold standard’’ for assessment of aortic stiffness in hyper-
tensive subjects. (1) PWV is included amongst the risk fac-
tors for cardiovascular disease (2) and is strongly predictive
for cardiovascular events in hypertensive individuals. (3)
An increase in aortic stiffness may increase the risk of
stroke through several mechanisms such as an increase in
central pulse pressure or an increase in carotid intima-
media thickness, promoting the development of atheroscle-
rotic lesions and thus the likelihood of plaque rupture.
In this issue, Lantelme et al. (4), propose an exciting,
alternative physiopathological approach. In agreement
with the precedent hypothesis, aortic stiffness is able to
influence the diameter of the left atrium and expose the
patient to embolic stroke by increasing their risk of atrial
fibrillation (AF). Indeed, this study shows that in a hyper-
tensive population recruited in their 50’s, to a referring
center in arterial hypertension, there was a significant
relationship between the diameter of the left atrium and
aortic stiffness (estimated from PWV measurements and
humeral pulse pressure). This relationship is independent
from other confounding factors, particularly cardiac
remodelling.
The interdependence between elastic aortic properties
and the left ventricular mass is well established particularly
with relative wall thickness, this relationship remains inde-
pendent from mean arterial pressure. So the expected cor-
relation is again found between the dimension of the left
atrium and the ventricular geometry, expressed as the rel-
ative wall thickness (RWT) and the left posterior wall thick-
ness measured in diastole (LPWT).
As suggested by P. Gosse and M. Safar in view of a com-
mon embryological origin, the aorta may be considered,
along with the left atrium and ventricle, as the third
chamber of the left sided cardiac pump transforming the
systolic output of the left ventricle into a continuous flow.
(5)
Although the physiopathological support for this work is
attractive, several limitations which are underligned by the
author, need to be discussed before considering the thera-
peutic angle. Correlations are established by accepting
“surrogate criteria”; the diameter of the left atrium for AF,
pro-BNP concentration for left ventricular diastolic func-
tion, peripheral pulse pressure (PP) for central pulse pres-
sure.
The hypothesis of the role of inflammation, raised in the
literature seems even more questionable and largely specu-
lative at this point to explain the risk of AF.
The pulse pressure, and as such arterial stiffness, is
closely associated with inflammation, as expressed by CRP
(6) or other cytokines, and raises further questions to the
development and the extent of atherosclerosis rather than
on the cause of atrial fibrillation.
* B. Chamontin, Service de médecine interne et hypertension artérielle, Pôle cardiovasculaire et métabolique, CHU Rangueil, Avenue
Jean Poulhès, TSA 50032 31059 Toulouse cedex 9, France. 
E-mail: chamontin.b@chu-toulouse.fr
10 B. Chamontin
The study illustrates the importance of considering tar-
get organ damage at the sub-clinical stage in the hyperten-
sive patient and reopens the question of a potential benefit
of anti-hypertensive agents beyond reduction in arterial
blood pressure. (7)
The favourable impact of antihypertensive treatment on
aortic stiffness may contribute to reduce the extent of
atherosclerosis, but also prevent the risk of the occurrence
of AF. (8)
According to recent clinical trials, the blockade of the
renin-angiotensin system (RAS) should be first-choice
agents, whose efficacy remains to be established prospec-
tively by targeting the relationship between aortic stiffness
and the left atrium.
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